Pedro Moliner
@petermoliner
MD, PhD. Coordinador de la Unidad de CardioOncología HUB-ICO. Unidad Multidisciplinar de Insuficiencia Cardiaca del Hospital de Bellvitge.
ID: 413367944
http://linkedin.com/in/pedro-moliner-borja-01761895 15-11-2011 20:08:14
2,2K Tweet
1,1K Followers
1,1K Following
Fascinating Nature Reviews Cardiology review by Dr. Bonnie Ky and team about the links between cardiovascular disease and cancer🫀🧬 nature.com/articles/s4156…
Anthracycline-induced cardiovascular toxicity: validation of the Heart Failure Association and International Cardio-Oncology Society risk score. #EHJ academic.oup.com/eurheartj/adva… #anthracycline #CVD #toxicity #HF European Society of Cardiology Journals European Society of Cardiology
Immunological therapies revolutionized #cancer treatment over the last decade. #CVtoxicities associated with these therapies emerged as an important consideration. I am honoured to contribute to this ESC/HFA position paper Heart Foundation Cancer Institute NSW …ry-wiley-com.ezproxy.newcastle.edu.au/doi/10.1002/ej…
Nuevas guías de #fibrilacionauricular de European Society of Cardiology #ESCCongress. Las guías son menos extensas que las previas 📂Documento disponible en academic.oup.com/eurheartj/adva… Vamos con mini-hilo 🧵con algunas de las principales novedades! ⤵️⤵️
SAVE THE DATE!! If interested in #CardioOnc, don’t miss the European Society of Cardiology Cardio-Oncology summit 2025 📅 20-21 June 2025 📍 Florence, Italy 🇮🇹 #ESCCongress #ESCCongress2024
🔥#ESC2024 SUCCOUR-MRI shows benefit of GLS-guided cardioprotection in patients treated w anthracyclines🔥 🔥Congratulations and 🙏Tom Marwick dineshpmcc & team! Time to add GLS European Society of Cardiology #CardioOnc risk stratification? European Society of Cardiology Journals Teresa López Fdez
SUCCOUR-MRI randomized pts w GLS decline to cardioprotection vs no treatment and showed benefit. Honored to write the Editorial with my #Oncology colleagues Inova Schar Cancer Institute on how this informs our joint care Inova European Society of Cardiology Journals academic.oup.com/eurheartj/arti…
✅After #ESCCongress we are facing a #HFpEF revolution‼️ ➡️From now a triple or quadruple therapy (in case of obesity) will be the cornerstone of therapy ➡️We need a practical comprehensive approach for established & emergent #HFpEF treatments ↪️So this is Nicolas Manito proposal:
Today was published the EMPACARD - PILOT Trial!!! The first prospective study using SGLT2i like prevention strategy of CTRCD!!! Thanks Vanesa Gregorietti Teresa López Fdez Diego Costa Lourdes M. Figueiras-Graillet Juan Carlos Plana Juliana Salas Joerg Herrmann iLACO International Cardio-Oncology Society Soc Esp Cardiología ACORA
In this #JACCCardioOnc review, Dr. David Gent, et al cover the breadth of what is known about #CVD in the adult #HCT population, focusing on acute & late complications, risk prediction, surveillance, & treatment of complications. bit.ly/3ZeW97w #CardioOnc